Quthero’s Clinical Trial Results Published in Prestigious Medical Journal
TORONTO, ONTARIO, CANADA, September 29, 2025 /EINPresswire.com/ — Quthero, a pioneering biotech company advancing regenerative medicine through its proprietary Q-peptide platform technology, announced today that the results of their recent clinical trial have been published in the September 2025 issue of the peer-reviewed Journal of Drugs in Dermatology. Quthero’s breakthrough technology enables complete regeneration of a patient’s natural tissue with minimal scarring. Read More>>